Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Deferred Taxes (2016 - 2025)

Conmed's Deferred Taxes history spans 16 years, with the latest figure at $812000.0 for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 87.65% year-over-year to $812000.0; the TTM value through Dec 2025 reached $3.5 million, down 71.13%, while the annual FY2025 figure was $3.5 million, 71.13% down from the prior year.
  • Deferred Taxes reached $812000.0 in Q4 2025 per CNMD's latest filing, down from $3.7 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $70.2 million in Q2 2022 to a low of -$44.5 million in Q4 2022.
  • Average Deferred Taxes over 5 years is $669400.0, with a median of $859500.0 recorded in 2021.
  • The largest YoY upside for Deferred Taxes was 7642.56% in 2022 against a maximum downside of 6900.0% in 2022.
  • A 5-year view of Deferred Taxes shows it stood at $4.3 million in 2021, then plummeted by 1130.68% to -$44.5 million in 2022, then surged by 103.58% to $1.6 million in 2023, then skyrocketed by 313.32% to $6.6 million in 2024, then plummeted by 87.65% to $812000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Deferred Taxes are $812000.0 (Q4 2025), $3.7 million (Q3 2025), and $1.7 million (Q2 2025).